FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death Read more
Bayer submits application in EU for extension of finerenone to include early stages of CKD associated with type-II diabetes Read more
Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes Read more